Network analysis-guided drug repurposing strategies targeting LPAR receptor in the interplay of COVID, Alzheimer’s, and diabetes

Abstract The COVID-19 pandemic caused by the SARS-CoV-2 virus has greatly affected global health. Emerging evidence suggests a complex interplay between Alzheimer’s disease (AD), diabetes (DM), and COVID-19. Given COVID-19’s involvement in the increased risk of other diseases, there is an urgent nee...

Descripció completa

Dades bibliogràfiques

Autors principals:	Dicson Sheeja Malar, Kanika Verma, Mani Iyer Prasanth, Tewin Tencomnao, James Michael Brimson
Format:	Artigo
Idioma:	Inglês
Publicat:	Nature Portfolio 2024-02-01
Col·lecció:	Scientific Reports
Matèries:	LPAR Alzheimer’s diseases Diabetes mellitus COVID-19 Docking Lupron
Accés en línia:	https://doi.org/10.1038/s41598-024-55013-9
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!